tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VSTM Stock Latest News

Verastem price target raised to $9 from $7 at Mizuho
The FlyVerastem price target raised to $9 from $7 at Mizuho
3d ago
VSTM
Verastem announces preliminary avutometinib and sotorasib data
PremiumThe Fly
Verastem announces preliminary avutometinib and sotorasib data
4d ago
VSTM
Verastem Inc. Reports Increased Operating Expenses and Net Loss
PremiumCompany Announcements
Verastem Inc. Reports Increased Operating Expenses and Net Loss
1M ago
VSTM
Verastem price target lowered to $14 from $20 at Alliance Global Partners
PremiumThe Fly
Verastem price target lowered to $14 from $20 at Alliance Global Partners
2M ago
VSTM
Verastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
PremiumThe Fly
Verastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
2M ago
VSTM
Verastem reports Q3 EPS (60c), consensus (74c)
PremiumThe FlyVerastem reports Q3 EPS (60c), consensus (74c)
2M ago
VSTM
Verastem completes rolling NDA submission to FDA for Avutometinib+Defactinib
Premium
The Fly
Verastem completes rolling NDA submission to FDA for Avutometinib+Defactinib
2M ago
VSTM
VSTM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VSTM Earnings this Week: How Will it Perform?
2M ago
VSTM
Truist remains bullish on Verastem, says weakness in shares ‘an overreaction’
PremiumThe Fly
Truist remains bullish on Verastem, says weakness in shares ‘an overreaction’
2M ago
VSTM
Verastem Advances Cancer Treatment with Promising Trial Results
PremiumCompany Announcements
Verastem Advances Cancer Treatment with Promising Trial Results
2M ago
8K
VSTM
Verastem presents updated data from RAMP 201 clinical trial
PremiumThe Fly
Verastem presents updated data from RAMP 201 clinical trial
2M ago
VSTM
Guggenheim starts Verastem with a Buy, sees ‘potential deep value opportunity’
PremiumThe Fly
Guggenheim starts Verastem with a Buy, sees ‘potential deep value opportunity’
3M ago
VSTM
Verastem initiated with a Buy at Guggenheim
PremiumThe FlyVerastem initiated with a Buy at Guggenheim
3M ago
VSTM
Verastem price target lowered to $7 from $17.50 at H.C. Wainwright
Premium
The Fly
Verastem price target lowered to $7 from $17.50 at H.C. Wainwright
4M ago
VSTM
Verastem reports Q2 EPS (61c), consensus (95c)
Premium
The Fly
Verastem reports Q2 EPS (61c), consensus (95c)
5M ago
VSTM
Verastem gets FDA Orphan Drug Designation for Avutometinib and Defactinib
PremiumThe Fly
Verastem gets FDA Orphan Drug Designation for Avutometinib and Defactinib
5M ago
VSTM
Verastem Inc (VSTM) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Verastem Inc (VSTM) Q2 Earnings Cheat Sheet
5M ago
VSTM
Verastem pancreatic cancer treatment granted orphan designation
PremiumThe Fly
Verastem pancreatic cancer treatment granted orphan designation
5M ago
VSTM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
PFE
ADIL
Verastem 13.333M share Spot Secondary priced at $3.00
PremiumThe FlyVerastem 13.333M share Spot Secondary priced at $3.00
5M ago
VSTM
Verastem announces offering of common stock, warrants
Premium
The Fly
Verastem announces offering of common stock, warrants
5M ago
VSTM
Verastem doses first patient in GFH375/VS-7375 trial
Premium
The Fly
Verastem doses first patient in GFH375/VS-7375 trial
5M ago
VSTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >